Phase 1 Breast Cancer Trial, Not Yet Recruiting NCT06195618 Sponsor: Universidad Nacional de Colombia Condition: Breast Cancer
Back to Breast Cancer

Phase 1 Breast Cancer Trial, Not Yet Recruiting

NCT06195618
Not Yet Recruiting Phase 1

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 75 years.
  • People with a confirmed diagnosis of primary triple negative breast cancer (a specific type of breast cancer identified through lab testing of tissue).
  • People who have already received treatment such as chemotherapy, radiotherapy, or surgery, and whose tumour has been found in previous research to have specific markers called "neoantigens" (unique proteins on the surface of cancer cells).
  • People with good venous access (veins that allow blood to be drawn easily).
  • People whose general physical functioning, as measured by a standard medical scale, is above a certain level (confirm with trial site).
  • People who weigh 50 kilograms or more.
  • People for whom the laboratory process of creating at least one personalised neoantigen from their tumour was successful.
  • People for whom a blood-collection procedure called apheresis was able to gather enough white blood cells for testing and for preparing a type of immune cell called dendritic cells.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with active or uncontrolled heart or blood vessel disease.
  • People who are pregnant or breastfeeding.
  • People who have other significant health conditions such as diabetes, kidney failure, or blood clotting disorders.
  • People who have been hospitalised within the last month.
  • People who have another active cancer, apart from certain skin cancers.
  • People who are currently taking part in another clinical trial.
  • People with a history of certain infectious diseases such as HIV, hepatitis, or tuberculosis.
  • People who are taking medications that suppress the immune system, such as corticosteroids (except those applied to the skin).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 29 July 2026

Contact this trial

Phone: 601-316-5000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 1
Sponsor
Universidad Nacional de Colombia
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
1 June 2027

Where this trial is recruiting

🇨🇴 Colombia

Primary endpoints

Number of adverse effects

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov